The antifungal drugs market size was valued at 16.6B in 2020, and is estimated to reach $25.0B by 2030, growing at a CAGR of 3.9% from 2021 to 2030, according to a report by Research & Markets.
Antifungal drugs selectively eliminate fungal infections from the host. These fungal agents multiply by spreading spores that subsequently lead to infection on skin, hairs, vagina, and other body parts. The fungal infection causes candidiasis, fungal pneumonia, mucormycosis, and other diseases. The antifungal drugs market is continuously growing and evolving, owing to robust developmental efforts made by researchers and market players in the field.
Factors that drive the growth of the global anti-fungal drugs market are growth in prevalence of fungal infection, rise in awareness levels pertaining to a myriad of fungal infections, and increase in demand for generic drugs.